title: Reduced dose pentostatin for initial management of hairy cell leukemia patients who have active infection or risk of hemorrhage is safe and effective.
authors.affiliation: The Ohio State University, Department of Internal Medicine, Division of Hematology, Columbus, OH leslie.andritsos@osumc.edu.
authors.forename: Leslie A
authors.initials: LA
authors.lastname: Andritsos
authors.affiliation: National Institutes of Health, National Heart, Lung, and Blood Institute, Hematology Branch, Bethesda, MD.
authors.forename: Neil
authors.initials: N
authors.lastname: Dunavin
authors.affiliation: The Ohio State University, Department of Pathology, Columbus, OH, USA.
authors.forename: Gerard
authors.initials: G
authors.lastname: Lozanski
authors.affiliation: The Ohio State University, Department of Internal Medicine, Division of Hematology, Columbus, OH.
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Jones
authors.affiliation: The Ohio State University, Department of Internal Medicine, Division of Hematology, Columbus, OH.
authors.forename: James S
authors.initials: JS
authors.lastname: Blachly
authors.affiliation: The Ohio State University, Department of Internal Medicine, Division of Hematology, Columbus, OH.
authors.forename: David M
authors.initials: DM
authors.lastname: Lucas
authors.affiliation: The Ohio State University, Department of Internal Medicine, Division of Hematology, Columbus, OH.
authors.forename: John C
authors.initials: JC
authors.lastname: Byrd
authors.affiliation: The Ohio State University, Department of Internal Medicine, Division of Hematology, Columbus, OH.
authors.forename: Eric
authors.initials: E
authors.lastname: Kraut
authors.affiliation: The Ohio State University, Department of Internal Medicine, Division of Hematology, Columbus, OH.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Grever
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019468:Disease Management; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006470:Hemorrhage / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007239:Infections / Q000150:complications / Q000188:drug therapy*; D007943:Leukemia, Hairy Cell / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D015649:Pentostatin / Q000627:therapeutic use*; D011379:Prognosis; D012074:Remission Induction
chemical_list: D000970:Antineoplastic Agents; D015649:Pentostatin
keywords: hairy cell leukemia; pentostatin